Abstract
The effect of cilostazol on human early endothelial progenitor cells (EPCs) is not well understood. This study aimed at the investigation of the effect of cilostazol on pro-angiogenesis functions in human early EPCs in vitro as well as therapeutic implication of hybrid therapy with cilostazol and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
